Carregant...
The next generation of immunotherapy: keeping lung cancer in check
Lung cancer is the deadliest malignancy with more cancer deaths per year than the next three cancers combined. Despite remarkable advances in targeted therapy, advanced lung cancer patients have not experienced a significant improvement in mortality. Lung cancer has been shown to be immunogenic and...
Guardat en:
| Publicat a: | J Hematol Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5402056/ https://ncbi.nlm.nih.gov/pubmed/28434399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0456-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|